Asafoetida
9 benefits mapped to clinical evidence across supplements.
Benefit Evidence
Reduced early satiety β81%
Less fullness/bloating β53% to β60%
Research sources
Antioxidant (1)
- Evaluation of the Potential Beneficial Effects of Ferula communis L. Extract Supplementation in Postmenopausal Discomfort
PubMed ID: 39203788
90βday RCT (Ferula communis) showed decreased plasma free radicals (dβROMs); related Ferula species so evidence is reasonably strong but indirect to asafoetida.
Inflammation (1)
- Evaluation of the Potential Beneficial Effects of Ferula communis L. Extract Supplementation in Postmenopausal Discomfort
PubMed ID: 39203788
Decreased plasma free radicals in a Ferula communis RCT suggests reduced oxidative/inflammatory burden (indirect to asafoetida).
Metabolism (1)
- Evaluation of the Potential Beneficial Effects of Ferula communis L. Extract Supplementation in Postmenopausal Discomfort
PubMed ID: 39203788
Ferula communis RCT produced a modest BMI reduction over 90 days, suggesting a metabolic effect (species differs from asafoetida).
Antimicrobial (1)
- Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study
PubMed ID: 41054174
Asafin shifted gut microbiome (F/B ratio fell ~72%), indicating microbiomeβmodulating or selective antimicrobial effects in the gut.
Appetite stimulation (1)
- Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study
PubMed ID: 41054174
Asafin reduced early satiety (β81%), which would be expected to increase appetite/meal tolerance.
Bloating & gas (1)
- Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study
PubMed ID: 41054174
Asafoetida (Asafin) 14βday RCT: bloating reduced β60% vs placebo β direct, large clinical effect.
Digestive support (1)
- Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study
PubMed ID: 41054174
Asafin RCT produced broad, significant improvements in dyspepsia symptoms (early satiety, fullness, bloating, heartburn, belching).
Relaxation (1)
- Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study
PubMed ID: 41054174
Asafin RCT improved sleep scores (BIS) and attention measures over 14 days, consistent with relaxation/sleep benefits.
Stomach comfort (1)
- Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study
PubMed ID: 41054174
Asafoetida RCT showed rapid, large reductions in multiple dyspepsia symptoms (direct evidence of soothing stomach/discomfort).
Similar by evidence
Supplements the same benefits carry qualifying findings for β a fact about the evidence graph, not a recommendation to swap.
Products with Asafoetida
Search all20 products whose verified label declares Asafoetida β not every bottle that mentions it in a title.